Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats

Hypertension

Volumn 32, Issue 3, 1998, Pages 467-472

  Otsuka, Shoji ^a   Sugano, Masahiro ^b   Makino, Naoki ^b   Sawada, Shojiro ^b   Hata, Tomoji ^b   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Collagen; Hypertrophy, vascular; Rats, inbred SHR; Receptors, angiotensin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; MESSENGER RNA; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA;

EID: 0031660492     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.3.467     Document Type: Article

References (39)

1. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safer M, Camilleri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res. 1988;63:227-239.
2. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff S, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989;64:1041-1050.
3. Adams MA, Bobik A, Korner PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension: relation to sympathetic function. Hypertension. 1989;14:191-202.
4. Korner P, Bobik A, Oddie C, Friberg P. Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension. 1993;22:243-252.
5. Johnson CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994;23: 258-268.
6. Paquet JL, Bandomin-Legros M, Brunelle G, Meyer P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens. 1990;8:565-572.
7. Geistefer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy but not hyperplasia of rat aortic smooth muscle cells. Circ Res. 1990;62:749-756.
8. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
9. Keeley FW, Elmoselhi A, Leenen FHH. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol. 1992;262:H1013-H1021.
10. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevents myointimal proliferation after vascular injury. Science. 1989;245: 186-188.
11. Yoshida H, Kakuchi J, Guo DF, Furuta H, Iwai N, Jong R, Inagami T, Ichikawa I. Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun. 1992;186:1042-1049.
12. de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Frew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;25:924-927.
13. Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine B, LeJemtel T, DeKock M. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation. 1993;88(pt 1):1602-1609.
14. Ichiki T, Labosky PA, Shiota C, Okuyama S, Inagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
15. Hei L, Barsh GS, Pratt RE, Dzau VJ, Koblika BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
16. 2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996;98:418-425.
17. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:1152-1156.
18. Widdop RE, Gardiner SM, Kemp PA, Bennett T. Central administration of PD123319 or EXP-3174 inhibits effects of angiotensin II. Am J Physiol. 1993;264:H117-H125.
19. Hayakari M, Kondoh Y, Ihumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem. 1978;84: 361-369.
20. Makino N, Sugano M, Otsuka S, Hata T. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension. 1997;30:796-802.
21. Sugano M, Makino N, Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Atherosclerosis. 1996;127:123-129.
22. Laurent GJ, Cockerill P, McAnulty RJ, Hastings JRB. A simplified method for quantification of the relative amounts of type I and type III collagen in small tissue samples. Anal Biochem. 1981;113:301-312.
23. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem. 1961; 35:1961-1965.
24. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol. 1996;28:507-517.
25. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond). 1991;351:233-236.
26. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-653.
27. Fort PH, Marty I, Piechaczyk M, Sabrouty SEI, Dani CH, Jeanteur PH, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
28. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safer ME, Benetos A. Angiotensin-converting enzyme inhibition prevents the increase in aortic collagen. Hypertension. 1994;23:74-82.
29. Owens GK. Influence of blood pressure on the development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987;9:178-187.
30. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Ishigami Y, Chatani F, Iwao H. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther. 1995;273:509-515.
31. 1 receptors in experimental and human hypertension. Can J Physiol Pharmacol. 1996;94:862-866.
32. Deyl Z, Jelinek J, Macek K, Chaldakov G, Vankov VN. Collagen and elastin synthesis in the aorta of spontaneously hypertensive rats. Blood Vessels. 1987;24:313-320.
33. Notoya M, Nakamura M, Mizojiri K. Effect of lisinopril on the structure of renal arterioles. Hypertension. 1996;27:364-370.
34. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension. 1991;17:141-150.
35. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol. 1997;17:257-264.
36. 1 antagonists. J Cardiovasc Pharmacol. 1995;26:66-72.
37. 1 receptor antagonism. Regul Peptides. 1997;68:111-117.
38. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 1994;23(pt 2):869-877.
39. Brilla CG, Matsbara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol. 1993;71:12A-16A.